| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $114.74 | $23.64 | 385.32% | 216.49x | 54.61x | 14.55x | 17.57x | 1.57x | $106.92M | 0.88% | $705.78M | 6.70 | $12.30B | 1,568.08 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.75 | $8.08 | 231.19% | 127.38x | 59.80x | 7.52x | 15.24x | 1.09x | $39.15M | 1.12% | $220.58M | 1.69 | $3.44B | 75.82 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $254.07 | $79.13 | 221.07% | 41.65x | 37.68x | 7.07x | 25.11x | 1.44x | $793.95M | 2.34% | $1.35B | 10.14 | $35.28B | 29.91 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $75.73 | $17.03 | 344.61% | 70.78x | 64.79x | 6.99x | 9.03x | 1.81x | $182.84M | 3.11% | $654.15M | 8.43 | $5.74B | 47.87 | ||
| RPRX | ROYALTY PHARMA PLC | $58.22 | $35.58 | 63.63% | 30.97x | 10.65x | 10.22x | 3.42x | 0.63x | $2.92B | 11.28% | $9.79B | 21.99 | $41.63B | 35.39 | ||
| HALO | HALOZYME THERAPEUTICS INC | $111.56 | $69.98 | 59.42% | 31.34x | 12.35x | 7.86x | 88.21x | 0.60x | $806.22M | 6.16% | $143.54M | 1.22 | $14.64B | 20.38 | ||
| VCEL | VERICEL CORP | $40.61 | $7.86 | 416.51% | 84.60x | 72.56x | 6.77x | 5.62x | 2.08x | $61.66M | 2.97% | $370.04M | 7.25 | $2.05B | 46.47 | ||
| KRYS | KRYSTAL BIOTECH INC | $335.06 | $82.57 | 305.78% | 40.52x | 42.93x | 22.46x | 7.30x | 2.16x | $257.78M | 2.61% | $1.36B | 46.03 | $9.50B | 40.72 | ||
| TGTX | TG THERAPEUTICS INC | $56.19 | $22.05 | 154.85% | 18.24x | 56.54x | 9.96x | 14.24x | 2.03x | $17.39M | 0.22% | $604.08M | 4.26 | $8.87B | 63.71 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.34 | $7.48 | 51.50% | 11.94x | 10.42x | 4.93x | 3.09x | 1.04x | $82.01M | 12.22% | $217.65M | 3.68 | $529.59M | 6.85 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.87 | $18.33 | 226.69% | 157.55x | 20.69x | 3.40x | 1.83x | 1.05x | $738.18M | 6.37% | $6.32B | 32.68 | $14.90B | 38.64 | ||
| MDXG | MIMEDX GROUP INC | $4.67 | $1.25 | 272.98% | 116.75x | -26.93x | 1.94x | 3.15x | 1.27x | $44.50M | 6.45% | $216.00M | 1.46 | $562.07M | 24.64 | ||
| EXEL | EXELIXIS INC | $58.65 | $29.51 | 98.76% | 17.83x | 17.73x | 6.04x | 7.88x | 1.17x | $1.17B | 7.97% | $1.84B | 7.35 | $14.42B | 13.25 | ||
| ADMA | ADMA BIOLOGICS INC | $9.96 | $6.86 | 45.14% | 13.83x | 12.52x | 4.44x | 5.47x | 0.81x | $116.47M | 5.12% | $408.21M | 1.79 | $2.29B | 9.84 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $526.73 | $145.91 | 260.99% | 30.39x | 27.51x | 10.62x | 6.59x | 2.28x | $3.80B | 2.84% | $20.25B | 79.81 | $129.34B | 23.50 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $232.35 | $177.29 | 31.06% | 15.23x | 9.09x | 3.19x | 3.14x | 0.63x | $1.62B | 11.03% | $4.80B | 75.98 | $17.86B | 11.05 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $310.36 | $84.43 | 267.59% | 30.82x | 32.85x | 21.43x | 6.39x | 2.33x | $130.62M | 2.10% | $967.52M | 48.22 | $6.31B | 22.62 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $750.51 | $420.83 | 78.34% | 17.89x | 13.38x | 4.97x | 2.44x | 0.95x | $3.76B | 4.87% | $31.71B | 308.48 | $77.52B | 13.48 | ||
| UTHR | UNITED THERAPEUTICS CORP | $481.47 | $185.50 | 159.55% | 15.92x | 18.02x | 6.50x | 3.23x | 2.92x | $1.09B | 5.33% | $6.40B | 150.24 | $18.85B | 11.24 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.29 | $29.60 | 32.76% | 12.51x | 9.43x | 2.37x | 2.29x | 0.75x | $354.90M | 15.59% | $999.24M | 17.25 | $1.89B | 6.76 | ||
| TECH | BIO-TECHNE CORP | $72.38 | $16.01 | 351.97% | 61.86x | 34.84x | 9.29x | 5.38x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.37B | 32.72 | ||
| VCYT | VERACYTE INC | $46.08 | $11.53 | 299.52% | 32.00x | 23.69x | 6.56x | 2.67x | 2.69x | $165.99M | 4.51% | $1.39B | 17.36 | $3.44B | 24.65 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $1.37 | -12.09% | 8.57x | -2.70x | 1.48x | 1.58x | 0.48x | $19.58M | 28.17% | $44.20M | 0.76 | $21.15M | 2.77 | ||
| INCY | INCYTE CORP | $123.20 | $57.93 | 112.65% | 15.17x | 34.75x | 4.24x | 3.94x | 1.71x | $1.92B | 7.78% | $6.34B | 31.66 | $21.02B | 10.16 |